



















![]()
BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2026 Earnings Call May 6, 2026 8:30 AM EDT
Company Participants
Nick Wilder - Manager of Investor Relations
Charles Gayer - CEO, President & Director
Sandeep Menon - Chief Research & Development Officer
Babar Ghias - CFO & Head of Corporate Development
Conference Call Participants
Laura Chico - Wedbush Securities Inc., Research Division
Brian Abrahams - RBC Capital Markets, Research Division
Steven Seedhouse - Cantor Fitzgerald & Co., Research Division
Stacy Ku - TD Cowen, Research Division
Maurice Raycroft - Jefferies LLC, Research Division
Catherine Okoukoni - Citizens JMP Securities, LLC, Research Division
Yesha Patel - Evercore ISI Institutional Equities, Research Division
Presentation
Operator
Good day, and welcome to the BioCryst First Quarter 2026 Earnings Conference Call. [Operator Instructions]
Please note, this event is being recorded. I would now like to turn the conference over to Nick Wilder. Please go ahead.
Nick Wilder
Manager of Investor Relations
Good morning, and welcome to BioCryst's First Quarter 2026 Corporate Update and Financial Results Conference Call.
Participating with me today are President and CEO, Charles Gayer; Chief R&D Officer, Dr. Sandeep Menon; and Chief Financial Officer, Babar Ghias.
A press release and slide presentation about today's news are available on our Investor Relations website. Today's call contains forward-looking statements, including statements regarding future results, unaudited and forward-looking financial information as well as the company's future performance and/or achievements. These statements are subject to known and unknown risks and uncertainties, which may cause our actual results, performance or achievements to be materially different from any future results or performance expressed or implied in this presentation. For additional information, including a detailed discussion of these risks, please refer to Slide 2 of the presentation.
In addition, today's conference call includes non-GAAP financial measures. For a reconciliation of these non-GAAP financial measures against the most directly comparable GAAP financial measure, please
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。